David Kirk is a freelance writer and communications consultant with interests in synthetic biology, biotech, and sustainability. He has a PhD in molecular microbiology and has industrial experience developing living medicines.

Articles by David Kirk

UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments

Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant

In Depth 7 Jan 2020

A Different Culture Shaping Synthetic Biology in Europe